U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2012
608
Name Type Language
raxibacumab [INN]
Preferred Name English
RAXIBACUMAB
DASH   INN   USAN   WHO-DD  
USAN   INN  
Official Name English
RAXIBACUMAB [MI]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(ANTHRAX PROTECTIVE ANTIGEN) (HUMAN MONOCLONAL PA HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL PAL-CHAIN, DIMER
Common Name English
Raxibacumab [WHO-DD]
Common Name English
RAXIBACUMAB [PURPLE BOOK CDER]
Common Name English
ABTHRAX
Brand Name English
RAXIBACUMAB [USAN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 21:25:01 GMT 2025 , Edited by admin on Mon Mar 31 21:25:01 GMT 2025
NDF-RT N0000192703
Created by admin on Mon Mar 31 21:25:01 GMT 2025 , Edited by admin on Mon Mar 31 21:25:01 GMT 2025
NCI_THESAURUS C52588
Created by admin on Mon Mar 31 21:25:01 GMT 2025 , Edited by admin on Mon Mar 31 21:25:01 GMT 2025
FDA ORPHAN DRUG 175503
Created by admin on Mon Mar 31 21:25:01 GMT 2025 , Edited by admin on Mon Mar 31 21:25:01 GMT 2025
EU-Orphan Drug EU/3/14/1352
Created by admin on Mon Mar 31 21:25:01 GMT 2025 , Edited by admin on Mon Mar 31 21:25:01 GMT 2025
WHO-ATC J06BB18
Created by admin on Mon Mar 31 21:25:01 GMT 2025 , Edited by admin on Mon Mar 31 21:25:01 GMT 2025
Code System Code Type Description
FDA UNII
794PGL549S
Created by admin on Mon Mar 31 21:25:01 GMT 2025 , Edited by admin on Mon Mar 31 21:25:01 GMT 2025
PRIMARY
CAS
565451-13-0
Created by admin on Mon Mar 31 21:25:01 GMT 2025 , Edited by admin on Mon Mar 31 21:25:01 GMT 2025
PRIMARY
NDF-RT
N0000192702
Created by admin on Mon Mar 31 21:25:01 GMT 2025 , Edited by admin on Mon Mar 31 21:25:01 GMT 2025
PRIMARY Anthrax Protective Antigen-directed Antibody Interactions [MoA]
SMS_ID
100000169810
Created by admin on Mon Mar 31 21:25:01 GMT 2025 , Edited by admin on Mon Mar 31 21:25:01 GMT 2025
PRIMARY
WIKIPEDIA
Raxibacumab
Created by admin on Mon Mar 31 21:25:01 GMT 2025 , Edited by admin on Mon Mar 31 21:25:01 GMT 2025
PRIMARY
USAN
QQ-32
Created by admin on Mon Mar 31 21:25:01 GMT 2025 , Edited by admin on Mon Mar 31 21:25:01 GMT 2025
PRIMARY
MERCK INDEX
m11685
Created by admin on Mon Mar 31 21:25:01 GMT 2025 , Edited by admin on Mon Mar 31 21:25:01 GMT 2025
PRIMARY
DRUG CENTRAL
4961
Created by admin on Mon Mar 31 21:25:01 GMT 2025 , Edited by admin on Mon Mar 31 21:25:01 GMT 2025
PRIMARY
RXCUI
1366567
Created by admin on Mon Mar 31 21:25:01 GMT 2025 , Edited by admin on Mon Mar 31 21:25:01 GMT 2025
PRIMARY RxNorm
DAILYMED
794PGL549S
Created by admin on Mon Mar 31 21:25:01 GMT 2025 , Edited by admin on Mon Mar 31 21:25:01 GMT 2025
PRIMARY
NCI_THESAURUS
C152160
Created by admin on Mon Mar 31 21:25:01 GMT 2025 , Edited by admin on Mon Mar 31 21:25:01 GMT 2025
PRIMARY
EVMPD
SUB183532
Created by admin on Mon Mar 31 21:25:01 GMT 2025 , Edited by admin on Mon Mar 31 21:25:01 GMT 2025
PRIMARY
INN
8580
Created by admin on Mon Mar 31 21:25:01 GMT 2025 , Edited by admin on Mon Mar 31 21:25:01 GMT 2025
PRIMARY
DRUG BANK
DB08902
Created by admin on Mon Mar 31 21:25:01 GMT 2025 , Edited by admin on Mon Mar 31 21:25:01 GMT 2025
PRIMARY
ChEMBL
CHEMBL2108638
Created by admin on Mon Mar 31 21:25:01 GMT 2025 , Edited by admin on Mon Mar 31 21:25:01 GMT 2025
PRIMARY
ACTIVE MOIETY
RAXIBACUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966